Kevin Limtao

Kevin Limtao is working in the In Vitro Technologies group leveraging his expertise in systems architecture, risk management, systems integration, and microfluidic design. For most of his career, Kevin has focused on early-phase product development in medical device and in vitro diagnostic applications. As a technical contributor, he developed immunoassays for automated platforms, instruments for surgical use, and devices for drug and sensor delivery. As a project leader, he led multidisciplinary teams from concept exploration through to design and integration. Most recently, Kevin worked at Ascensia Diabetes Care (formerly Bayer) where he led systems engineering efforts for products undergoing global regulatory submissions.

Kevin received his B.S. in Biomedical Engineering from UC Irvine where his microfluidic research focused on numerous applications such as the capture of circulating tumor cells and small sample Western Blotting. He is a co-inventor on two patents and his contributions have been presented at engineering conferences such as Pittcon, µTAS, ECTC, and BMES.